icon-folder.gif   Conference Reports for NATAP  
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
Long-term Follow-up of Patients With Chronic HCV Infection and Compensated or Decompensated Cirrhosis Following Treatment With Sofosbuvir-Based Regimens
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Andrew J. Muir,1 Maria Buti,2 Ronald Nahass,3 Kosh Agarwal,4 Edward J. Gane,5 Simone I. Strasser,6 Alessandra Mangia,7 Jose Luis Calleja Panero,8 Kathryn Kersey,9 Stephanie Moody,10 Diana M. Brainard,9 Paul Marotta,11 Marc Bourliere,12 Bruce Bacon,13 Bradley Freilich,14 Michael P. Curry15
1Duke University, Durham, NC; 2Vall d'Hebron Hospital, Barcelona, Spain; 3ID Care, Hillsborough, NJ; 4Institute of Liver Studies, King's College Hospital, London, UK; 5Auckland Clinical Studies Ltd, Auckland, New Zealand; 6Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; 7Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; 8Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain; 9Gilead Sciences, Inc., Foster City, CA; 10PharPoint Research, Inc., Durham, NC; 11London Health Sciences Centre, Western University, London, Ontario, Canada; 12H˘pital-Saint Joseph Marseille, France; 13SSM Health Saint Louis University Hospital, St. Louis, MO; 14Kansas City Research Institute, Kansas City, MO; 15Beth Israel Deaconess Medical Center, Boston, MA